FierceBiotech 9 déc. 2025 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Endpoints News 5 déc. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
FierceBiotech 5 déc. 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
Roche Media 4 déc. 2025 Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance
Endpoints News 4 déc. 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
FierceBiotech 3 déc. 2025 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
Endpoints News 2 déc. 2025 Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a> #mRNA flu #Pfizer mRNA
PharmaVoice 17 nov. 2025 Developing a path forward in cancer cachexia #Pfizer scientists #cachexia Pfizer
Lonza News 7 oct. 2025 Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report